Finance

Lists
CSG:AMS
CSG NV
€17.85
+0.77%
(+0.14) 1D
Aug 10, 9:49:17 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for CSG...
Open
€17.90
High
€18.00
Low
€17.44
Mkt. cap
17.87B
Avg. vol.
1.09M
Volume
187.20K
P/E ratio
21.38
52-wk high
€35.50
52-wk low
€12.20
EPS
€0.84
Shares outstanding
1.00B
No. of employees
11K
Open
€17.90
High
€18.00
Low
€17.44
Mkt. cap
17.87B
Avg. vol.
1.09M
Volume
187.20K
P/E ratio
21.38
52-wk high
€35.50
52-wk low
€12.20
EPS
€0.84
Shares outstanding
1.00B
No. of employees
11K
News stories
From sources across the web
Profile
The Czechoslovak Group, formerly Excalibur Group, is a Czech industrial-technological holding company encompassing over 100 companies with over 14,000 employees worldwide. Headquartered in Prague, CSG operates in several sectors including defense, aerospace, ammunition, automotive, and railway industries. Since January 2018, the owner of the Czechoslovak Group is Michal Strnad, the son of the founder, Jaroslav Strnad. In 2025, Michal Strnad stated that his aim is to grow the Czechoslovak Group into the second largest European defense manufacturer. While bulk of the CSG's operations is based in the Czech Republic and Slovakia, CSG also operates factories in Germany, Greece, India, Italy, Serbia, Spain, the United Kingdom and the United States. In 2024, the company became one of the world's largest manufacturers of small arms ammunition through acquisition of The Kinetic Group. In 2024, 78% of CSG's revenue originated from defense-related manufacturing, with small arms ammo manufacturing contributing further 11.3%. CSG exported its products to over 70 countries, with 50% of the CSG's revenue realized in NATO states and 42% in Ukraine. Wikipedia
About CSG NV
CEO-
Employees10.6K
Founded1995
Headquarters-
SectorAerospace and Defense
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
2.26B
1.54B
1.71B
Cost of goods sold
-
1.35B
854.00M
1.53B
Cost of revenue
-
1.35B
854.00M
1.53B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
365.28M
296.00M
-296.00M
Operating expense
-
367.29M
317.00M
-239.00M
Total operating expenses
-
1.72B
1.17B
1.30B
Operating income
-
540.68M
373.00M
412.00M
Other non operating income
-
21.75M
20.00M
-21.00M
EBT including unusual items
-
485.15M
385.00M
343.00M
EBT excluding unusual items
-
476.05M
388.00M
340.00M
Income tax expense
-
124.14M
86.00M
71.00M
Effective tax rate
-
25.59%
22.34%
20.70%
Other operating expenses
-
-36.27M
-18.00M
18.00M
Net income
-
290.74M
299.00M
272.00M
Net profit margin
-
12.89%
19.37%
15.93%
Earnings per share
-
-
-
-
Interest and investment income
-
13.05M
148.00M
96.00M
Interest expense
-
-99.83M
-157.00M
-148.00M
Net interest expenses
-
-86.78M
-9.00M
-52.00M
Depreciation and amortization charges
-
38.28M
39.00M
39.00M
EBITDA
-
592.19M
412.00M
451.00M
Gain or loss from assets sale
-
7.00K
2.00M
-2.00M
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps